Whalesbook
Mixed IPO Listings Show Divergent Investor Interest
The recent quiet period in the primary market has shifted focus to the listings of four mainboard IPOs, revealing a sharp contrast in investor appetite. Central Mine Planning & Design Institute (CMPDI), a dominant player in its sector, had a tepid market debut. Meanwhile, Powerica and Amir Chand Jagdish Kumar (Exports) attracted stronger investor interest. This difference in performance highlights key factors influencing investment decisions: favorable sector trends, careful valuation, and broader economic pressures.
CMPDI's Quiet Debut Contrasts with Stronger Demand for Others
Central Mine Planning & Design Institute (CMPDI) listed on March 30th, 2026, with subdued enthusiasm and a low grey market premium, suggesting expectations of a flat debut. This was despite its strong market position, holding about 61% of India's coal and mineral consultancy market share. The ₹1,842-crore offer, entirely an Offer for Sale (OFS) – meaning no new capital was raised for the company – was subscribed 1.05 times, with institutional investors showing moderate interest. This quiet reception, even with a reasonable post-IPO P/E of 21.65x (between competitors Engineers India at 19.9x and RITES at 25.2x), suggests that a lack of fresh capital and few high-growth catalysts may have cooled investor optimism. In contrast, Powerica and Amir Chand Jagdish Kumar (Exports) had a better reception. Powerica's ₹1,100-crore issue was subscribed 3.67 times, supported by its plans for renewable energy and debt reduction. Amir Chand Jagdish Kumar (Exports)'s ₹440-crore offering also saw healthy demand, subscribed 3.23 times, likely driven by its established basmati rice export brand and plans to expand into branded domestic products.
Valuations and Market Sentiment Shape IPO Demand
The four IPOs highlight distinct investor approaches. CMPDI, valued at ₹12,281 crore post-IPO with a P/E of about 21.65x, seems fully priced rather than offering a discount, potentially explaining the subdued Qualified Institutional Buyer (QIB) subscription. Its FY25 revenue was ₹2,177.53 crore, with net profit (PAT) of ₹666.91 crore. Amir Chand Jagdish Kumar (Exports) is valued at a FY25 P/E of 22.6x to 36.1x, considered fairly valued against basmati peers. This is supported by strong export business and ambitious expansion plans, showing impressive growth rates (CAGRs) of 23.3% for revenue and 86.5% for net profit between FY23-FY25. Powerica, seeking ₹1,100 crore, is valued at a FY25 P/E of approximately 28x, competitive against peers like Cummins (52x) and Kirloskar Oil Engines (34x). Its strategy includes debt reduction and expanding its renewable energy business. Sai Parenteral, however, faces significant valuation challenges. Its pre-IPO P/E of 72.19x and FY25 P/E of around 88.2x are much higher than peers like Innova Captab (32.45x P/E) and Gland Pharma (44.71x P/E), suggesting its ₹408.79 crore IPO might be overpriced. Broader market sentiment in March 2026 was cautious, with the benchmark Sensex declining over 8%. Geopolitical tensions, rising crude oil prices, and consistent foreign institutional investor (FII) outflows weighed heavily on investor confidence. While the Indian IPO market overall remains active, listing gains have slowed, indicating a more selective investor base. IT and banking sectors underperformed, while energy and PSU stocks were resilient, as investors sought safer assets amid uncertainty.
Risks and Challenges for Each IPO
Despite their strengths, each company faces specific challenges. CMPDI's Offer for Sale (OFS) structure means no new capital for growth. It also faces revenue and client concentration risks, with heavy reliance on Coal India and government policies. While its margins are strong, its 'fully priced' valuation might limit short-term gains. Powerica's operational efficiency is being watched due to falling net profit and EBITDA margins, which decreased to 12.76% in FY25 from 15.38% in FY24. Furthermore, its significant reliance on one engine supplier and a small wind portfolio pose considerable dependence risks. Legal issues and potential cost increases also add to its risks. Sai Parenteral's high valuation is a primary concern; its P/E multiples are much higher than larger, established peers. Beyond valuation, regulatory compliance, pricing pressures, and risks in scaling up operations pose major threats. For Amir Chand Jagdish Kumar (Exports), risks are inherent to the agri-export sector, including commodity price volatility, monsoon dependence, and potential government actions like export bans. The lack of product liability insurance is also a notable governance issue.
Analyst Views and Market Outlook
Analysts have mixed views on Sai Parenteral. Some suggest a long-term 'subscribe' based on growth prospects, while others warn about its high valuations. Powerica has received 'subscribe' ratings from some brokerages for long-term investors, citing fair valuations and demand visibility from data centers, though concerns about falling margins remain. Amir Chand Jagdish Kumar (Exports) is also recommended for long-term investors, backed by its growth and brand strength. CMPDI's outlook is limited by its OFS structure and 'fully priced' valuation; some see it as a stable, but not high-growth, investment. The IPO market overall in 2026 is expected to remain active but marked by greater selectivity, favoring companies with clear growth stories, strong financials, and sensible valuations.